Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KetHead
NCT05306899Phase 3Recruiting
- Sponsor
- University Health Network
- Start
- Jun 2022
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in chronic daily headache (CDH), sponsored by University Health Network. Started Jun 2022; status: recruiting.
02
Drugs
ketamine
03
Conditions
chronic daily headache (CDH)
Beyond the preview
Go deeper on NCT05306899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306899.